Danone S.A. (OTCQX:DANOY) Q4 2022 Earnings Conference Call February 22, 2023 2:30 AM ET Company Participants Mathilde Rodie - Head of IR Antoine de Saint-Affrique - CEO Juergen Esser - CFO Conference Call Participants Jon Cox - Kepler Chevreux Guillaume Delmas - UBS John Ennis - Goldman Sachs Bruno Monteyne - Bernstein Patrick Folan - Barclays Tom Sykes - Deutsche Bank David Hayes - Societe Generale Celine Pannuti - JPMorgan Operator Good day, and thank you for standing by. Welcome to Danone 2022 Annual Res ...

Danone S.A. (OTCQX:DANOY) Q2 2022 Earnings Conference Call July 27, 2022 2:30 AM ET Company Participants Mathilde Rodie - Head of Investor Relations Antoine de Saint-Affrique - Chief Executive Officer Juergen Esser - Chief Financial Officer Conference Call Participants Jon Cox - Kepler Bruno Monteyne - Bernstein Pascal Boll - Stifel Jeremy Fialko - HSBC John Ennis - Goldman Sachs Celine Pannuti - JPMorgan David Hayes - Societe Generale Mathilde Rodie Thank you. Good morning, everyone. Mathilde Rodie speakin ...

HALF-YEAR 2022 RESULTS July 27, 2022 DISCLAIMER - This presentation contains certain forward-looking statements concerning Danone. In some cases, you can identify these forward-looking statements by forward-looking words, such as "estimate", "expect", "anticipate", "project", "plan", "intend", "objective", "believe", "forecast", "guidance", "outlook", "foresee", "likely", "may", "should", "goal", "target", "might", "will", "could", "predict", "continue", "convinced" and "confident," the negative or plural o ...

Danone S.A. (OTCQX:DANOY) Q4 2021 Earnings Conference Call February 23, 2022 3:00 AM ET Company Participants Mathilde Rodie - Head of Investor Relations Antoine de Saint-Affrique - Chief Executive Officer Juergen Esser - Chief Financial Officer Conference Call Participants Guillaume Delmas - UBS Warren Ackerman - Barclays Celine Pannuti - JPMorgan Bruno Monteyne - Bernstein Martin Deboo - Jefferies Jeremy Fialko - HSBC John Ennis - Goldman Sachs Disclaimer*: This transcript is designed to be used alongside ...

Financial Data and Key Metrics Changes - The company reported a like-for-like growth of 1.6% for H1 2021, with Q2 showing a strong recovery at 6.6% growth [7][48] - The recurring operating margin for H1 2021 was 13.1%, down 86 basis points from the previous year, primarily due to negative category mix and inflationary pressures [40][70] - Net sales for Q2 reached approximately €6.2 billion, up from €6 billion in the previous year, reflecting a reported growth of 3.6% [50] Performance by Business Line - The Essential Dairy and Plant-based (EDP) division grew by 3.2% in H1, with Q2 growth accelerating to 4.8% [59][60] - Specialized Nutrition saw a decline of 2.6% in H1 but returned to growth in Q2 at 2.8% [51][52] - The Waters division reported a 4.5% increase in H1, with Q2 growth at 19.5% [65][67] Market Data and Key Metrics Changes - In Europe, the EDP division delivered around 4% growth, with significant contributions from Alpro and Probiotics [61] - North America saw a return to growth in the yogurt business, particularly in Greek and Probiotics segments [62] - Emerging markets, particularly in Latin America and Indonesia, contributed to growth but remained impacted by COVID-related restrictions [14][69] Company Strategy and Development Direction - The company is focusing on three strategic priorities: strengthening core business, executing successful innovations, and selective investment in growth platforms [16][22] - The "Local First" reorganization aims to enhance local market responsiveness and operational efficiency, with a target of €700 million in gross savings by 2023 [41][42] - Continued emphasis on sustainability and innovation in product offerings, particularly in the Plant-based segment [25][28] Management's Comments on Operating Environment and Future Outlook - Management acknowledged significant inflationary pressures, reaching nearly 7% in H1, and expects further acceleration in the second half [36][85] - The company remains committed to maintaining strategic investments despite inflation, aiming for profitable growth in H2 [86] - Management expressed confidence in the recovery of the Waters division and overall positive momentum across categories [69][86] Other Important Information - The company plans to initiate a share buyback program of up to €800 million following the disposal of its stake in Mengniu [80] - Free cash flow for H1 2021 reached €1 billion, indicating improved cash conversion [78] Q&A Session Summary Question: Plant-based growth specifics and Greek yogurt recovery - Management highlighted a 12% growth in Plant-based products, driven by strong performance in Europe and North America, with specific plans to address the oat segment [90][91] - The recovery in Greek yogurt is attributed to the successful restaging of the Oikos brand and new product launches [94] Question: A&P spend and cost savings - A&P investments were focused on strategic brands, with plans for continued reinvestment in the second half [96] - Cost savings reached nearly 5% in H1, with expectations for further savings in H2 [98] Question: Specialized Nutrition in China - Management indicated a positive outlook for the domestic channel in China, with expectations for margin progression in the second half [110][111] - The Aptamil brand continues to gain market share, supported by strong performance in e-commerce [112]

Danone SA (OTCQX:DANOY) Q4 2020 Earnings Conference Call February 1, 2020 3:00 AM ET Company Participants Mathilde Rodié - Head IR and Financial Communication Emmanuel Faber - Chairman & CEO Juergen Esser - Chief Financial, Technology and Data Officer, Conference Call Participants Warren Ackerman - Barclays Bank Guillaume Delmas - UBS Celine Pannuti - JPMorgan Chase & Co. Richard Taylor - Morgan Stanley Jon Cox - Kepler Cheuvreux John Ennis - Goldman Sachs Group Jeremy Fialko – HSBC Operator Ladies and gent ...

I 1 I FY 2020 RESULTS February 19th, 2021 Disclaimer • This presentation contains certain forward-looking statements concerning Danone. In some cases, you can identify these forward-looking statements by forward-looking words, such as "estimate", "expect", "anticipate", "project", "plan", "intend", "objective", "believe", "forecast", "guidance", "outlook", "foresee", "likely", "may", "should", "goal", "target", "might", "will", "could", "predict", "continue", "convinced" and "confident," the negative or plu ...

Q3 2020 SALES A new world: Deliver. Reshape. Review. Adapt. October 19th, 2020 Emmanuel Faber Cécile Cabanis I 1 I Disclaimer • This presentation contains certain forward-looking statements concerning Danone. In some cases, you can identify these forward-looking statements by forward-looking words, such as "estimate", "expect", "anticipate", "project", "plan", "intend", "objective", "believe", "forecast", "guidance", "outlook", "foresee", "likely", "may", "should", "goal", "target", "might", "will", "could" ...

Danone SA (OTCQX:DANOY) Q2 2020 Earnings Conference Call July 30, 2020 3:00 AM ET Company Participants Nadia Ben Salem-Nicolas - Head, IR and Financial Communication Emmanuel Faber - Chairman & CEO Cécile Cabanis - EVP, Technology, Data, Cycles & Procurement, CFO and Director Conference Call Participants Warren Ackerman - Barclays Bank Celine Pannuti - JPMorgan Chase & Co. Alan Erskine - Crédit Suisse John Ennis - Goldman Sachs Group Richard Taylor - Morgan Stanley Operator Ladies and gentlemen, thank you f ...

I 1I DANONE HALF-YEAR 2020 RESULTS Resilience confirmed Set to emerge stronger July 30th, 2020 Emmanuel Faber Cécile Cabanis BONAFON Disclaimer • This presentation contains certain forward-looking statements concerning Danone. In some cases, you can identify these forwardlooking statements by forward-looking words, such as "estimate", "expect", "anticipate", "project", "plan", "intend", "objective", "believe", "forecast", "guidance", "outlook", "foresee", "likely", "may", "should", "goal", "target", "might" ...